Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
New research from Columbia Neurologist Dr. Claire Riley and Nurse Practitioner Libby Levine sheds light on the potential complications of B-cell suppressing therapies in women with multiple sclerosis.
A new collaborative study by Drs. Martin Picard and Philip L. De Jager examines the potential link between the brain's mitochondria and a person's psychological stress.
New study lead by Jan Claassen, MD, FNCS, Professor of Neurology and Chief of Critical Care and Hospitalist Neurology at NYP/CUIMC, has identified brain injuries that may underlie hidden consciousness
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion
Two inaugural awards in the field of neurodegeneration were announced today as part of the Carol and Gene Ludwig Center for Research on Neurodegeneration.
Mitchell S.V. Elkind, MD, MS, MPhil, Professor of Neurology & Epidemiology, comments on the new study & recommendation of taking daily baby aspirin to help prevent first-time heart attack or stroke
Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug
Andrew B. Lassman, MD, Professor of Neurology & Associate Dean of Clinical Trials at Columbia University, talks about the importance of enrolling a diverse population of subjects in clinical trials
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, and colleagues led a study that found eye drop treatment alternative to Retinal vein occlusion (RVO) disease
Adam M. Brickman, PhD, Professor of Neuropsychology, and Scott A. Small, MD, Boris and Rose Katz Professor of Neurology, discuss their study that examined health benefits of flavanol-rich diet
Scott Small, MD, Boris & Rose Katz Professor of Neurology and Director & Alzheimer's Disease Research Center at CUIMC talks about the study that examined flavanols levels and memory loss
Adam M. Brickman, PhD, Professor of Neuropsychology, and colleagues conducted a large study that found that taking a daily multivitamin supplement can slow age-related memory decline